CUV clinuvel pharmaceuticals limited

Excellent research report Parmantier indicates 26AUS price target

  1. 21 Posts.
    lightbulb Created with Sketch. 31
    While researching how to vote on the Remuneration report I came across an excellent research report published by Parmantier (9/9/2024), well written & well researched with some new facts (especially around CUV competition) that were new to me. Highly suggest that any investor that has CUV or is thinking about buying/sell read this:

    direct link:
    https://cdn.prod.website-files.com/66d025412a2cb352455e5880/66dee0587e92591c87344e8a_24_09_CUV_PCR_Initial%20Study_engl_240906_VO%20final%203.0.pdf

    or via their website:
    https://www.parmantiercie.com/research

    Last edited by MartiniMayhem: 13/09/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$11.24
Change
0.440(4.07%)
Mkt cap ! $563.3M
Open High Low Value Volume
$11.00 $11.45 $10.88 $1.450M 129.6K

Buyers (Bids)

No. Vol. Price($)
3 6377 $11.15
 

Sellers (Offers)

Price($) Vol. No.
$11.25 253 1
View Market Depth
Last trade - 16.10pm 16/09/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.